Kalpit Patel

Q: What is Kalpit Patel's success rate?

Kalpit Patel currently has a success rate of 89.6176447879338.

Q: What is the average return of Kalpit Patel's calls?

Their stock ratings have generated an average return of 50.51363211815115.

Wolfe Research | Healthcare

Kalpit Patel is an analyst from Wolfe Research specializing in the Healthcare sector. Ranked #346 out of 4773 analysts, they have issued 19 stock ratings with a success rate of 89.62% and an average return of 50.51%.

With 19 ratings to date, Kalpit Patel is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 89.62% and an average return of 50.51%, highlighting promising potential as their track record develops further.

#346

Out of 4773

Total Ratings

+89.62%

Success Rate

+50.51%

Average Return

Recent Ratings Analysis

JANX

Buy

Aug 24, 2026

Target

$23.00

Current

$17.10

Performance

-8.06%

Kalpit Patel rated JANX as Outperform on Aug 24, 2026, setting a price target of 23. The stock has underperformed, dropping 8.06% despite the bullish target of 23.

CORT

Sell

Jul 27, 2026

Target

$50.00

Current

$112.79

Performance

23.78%

On Jul 27, 2026, CORT was given a Underperform rating by Kalpit Patel, with a target price of 50. The Sell stance aligned with downward action, with the stock sliding from 112.79 to 112.79.

KYMR

Buy

Jun 29, 2026

Target

$155.00

Current

$114.96

Performance

5.16%

KYMR received a Buy rating from Kalpit Patel on Jun 29, 2026, aiming for 155. Momentum has favored the Buy call, with shares climbing from 114.96 to 114.96, rewarding those who trusted the recommendation.

MIRM

Buy

May 19, 2026

Target

$145.00

Current

$98.22

Performance

2.69%

On May 19, 2026, Kalpit Patel published a Outperform outlook on MIRM, with a target of 145. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 98.22.

GMAB

Buy

Mar 27, 2026

Target

$32.00

Current

$32.47

Performance

25.76%

Kalpit Patel on Mar 27, 2026 assigned GMAB a Outperform rating, with a price target of 32. The Buy call aligned well with market performance, producing a gain of 25.76%.

ONC

Buy

Mar 27, 2026

Target

$340.00

Current

$346.51

Performance

22.43%

On Mar 27, 2026, Kalpit Patel reaffirmed ONC with a Outperform rating, targeting 340. The recommendation was supported by strong follow-through as the stock rose from 346.51 to 346.51.

AVBP

Buy

Mar 23, 2026

Target

$45.00

Current

$29.00

Performance

30.75%

AVBP was rated Buy by Kalpit Patel on Mar 23, 2026, with a price objective of 45. A bullish response from the market helped close the gap of 16.00 to the target.

PDSB

Buy

Nov 25, 2025

Target

$5.00

Current

$0.29

Performance

-60.45%

On Nov 25, 2025, Kalpit Patel initiated coverage on PDSB with a Buy rating and target of 5. The Buy call has yet to be validated as shares remain 4.71 away from the target.

RVMD

Buy

Nov 18, 2025

Target

$75.00

Current

$203.77

Performance

188.71%

Kalpit Patel issued a Outperform recommendation for RVMD on Nov 18, 2025, price target set at 75. Investors following the Buy call captured upside momentum, with shares now at 203.77.

ACLX

Hold

Nov 18, 2025

Target

—

Current

$115.07

Performance

27.87%

On Nov 18, 2025, ACLX was evaluated by Kalpit Patel, who gave a Peer Perform rating and target of null. Investors who stayed in despite the Hold saw upside of 27.87%.

CELC

Buy

Nov 18, 2025

Target

$110.00

Current

$83.45

Performance

-8.90%

Kalpit Patel rated CELC as Outperform on Nov 18, 2025, setting a price target of 110. The stock has underperformed, dropping 8.90% despite the bullish target of 110.

ORIC

Hold

Nov 18, 2025

Target

—

Current

$12.04

Performance

1.18%

On Nov 18, 2025, ORIC was given a Peer Perform rating by Kalpit Patel, with a target price of null. Market indecision, reflected in sideways trading near 12.04, supported the cautious call.

SLNO

Buy

Nov 18, 2025

Target

$75.00

Current

$53.01

Performance

9.21%

SLNO received a Outperform rating from Kalpit Patel on Nov 18, 2025, aiming for 75. Momentum has favored the Buy call, with shares climbing from 53.01 to 53.01, rewarding those who trusted the recommendation.

SMMT

Hold

Nov 18, 2025

Target

—

Current

$17.55

Performance

4.40%

On Nov 18, 2025, Kalpit Patel published a Peer Perform outlook on SMMT, with a target of null. Sideways action left the Hold view intact, with no major move since 17.55.

SRRK

Buy

Nov 18, 2025

Target

$42.00

Current

$55.41

Performance

39.19%

Kalpit Patel on Nov 18, 2025 assigned SRRK a Outperform rating, with a price target of 42. The Buy call aligned well with market performance, producing a gain of 39.19%.

TNGX

Hold

Nov 18, 2025

Target

—

Current

$23.78

Performance

197.25%

On Nov 18, 2025, Kalpit Patel reaffirmed TNGX with a Peer Perform rating, targeting null. Market strength beyond 23.78 went further than the conservative outlook suggested.

DERM

Buy

Jul 30, 2025

Target

$12.00

Current

$7.23

Performance

-4.74%

DERM was rated Buy by Kalpit Patel on Jul 30, 2025, with a price objective of 12. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

RIGL

Hold

Mar 05, 2025

Target

$24.00

Current

$47.24

Performance

132.82%

On Mar 05, 2025, Kalpit Patel initiated coverage on RIGL with a Neutral rating and target of 24. The Hold stance underestimated the stock’s strength as it gained 132.82%.

GERN

Buy

Feb 18, 2025

Target

$3.50

Current

$1.35

Performance

-48.67%

Kalpit Patel issued a Buy recommendation for GERN on Feb 18, 2025, price target set at 3.5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

VSTM

Buy

Jan 31, 2025

Target

$9.00

Current

$7.32

Performance

20.39%

On Jan 31, 2025, VSTM was evaluated by Kalpit Patel, who gave a Buy rating and target of 9. This case illustrates how a timely bullish rating can translate into tangible gains of 20.39%.

FHTX

Buy

Jan 30, 2025

Target

$10.00

Current

$4.42

Performance

1.84%

Kalpit Patel rated FHTX as Buy on Jan 30, 2025, setting a price target of 10. Shares have remained stable near 4.42, leaving the 10 target still in play.

BCYC

Hold

Dec 13, 2024

Target

$17.00

Current

$3.86

Performance

-72.05%

On Dec 13, 2024, BCYC was given a Neutral rating by Kalpit Patel, with a target price of 17. The rating provided protection from downside risk as the stock fell to 3.86.

LBPH

Hold

Oct 14, 2024

Target

$60.00

Current

$59.98

Performance

1.68%

LBPH received a Neutral rating from Kalpit Patel on Oct 14, 2024, aiming for 60. Shares remained flat at 59.98, aligning with the neutral rating.

CRBP

Buy

Sep 20, 2024

Target

$40.00

Current

$8.12

Performance

-58.38%

On Sep 20, 2024, Kalpit Patel published a Buy outlook on CRBP, with a target of 40. Market action contradicted the Buy thesis, as shares slipped to 8.12.

OVID

Buy

Jun 18, 2024

Target

$3.00

Current

$2.69

Performance

241.41%

Kalpit Patel on Jun 18, 2024 assigned OVID a Buy rating, with a price target of 3. The Buy call aligned well with market performance, producing a gain of 241.41%.

VRDN

Hold

May 09, 2024

Target

$20.00

Current

$21.24

Performance

52.70%

On May 09, 2024, Kalpit Patel reaffirmed VRDN with a Neutral rating, targeting 20. Market strength beyond 21.24 went further than the conservative outlook suggested.

Frequency Asked Questions

Who is Kalpit Patel?

Kalpit Patel is an analyst from Wolfe Research specializing in the Healthcare sector.

What is Kalpit Patel's success rate?

Kalpit Patel currently has a success rate of +89.62%.

How many ratings has Kalpit Patel issued?

Kalpit Patel has issued 19 stock ratings so far.

What is the average return of Kalpit Patel's calls?

Their stock ratings have generated an average return of +50.51%.

What is Kalpit Patel's ranking?

Kalpit Patel is ranked #346 out of 4773 analysts.

What types of ratings does Kalpit Patel give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kalpit Patel?

You can follow Kalpit Patel by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kalpit Patel?

Their latest rating was a Buy on JANX issued on 2026-08-24.